Science bee - Gene Editing & Bio-Grid Overview - Vaccines, CAR T-cell Therapy, Cord Blood, BharOS, Doxxing, Hermit

Sep 20, 2026

Upload by Eden

Material explains gene-editing limitations, emphasizing why directly editing specific memories or introducing entirely new complex traits is currently beyond reach. It outlines the Bio-Grid concept as a national biological data repository and describes vaccine platforms, including ZyCoV-D, Covaxin, Covishield, and Moderna, with their basic mechanisms. It also summarizes CAR T-cell therapy principles, cord blood banking considerations, and introduces BharOS features. The text further defines doxxing and concludes with Hermit spyware background and notoriety.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages13

Reading Time33 min

AccessFree to download

Gene editing limitations

Bio-Grid and vaccine platforms

ZyCoV-D, Covaxin, Covishield, Moderna

CAR T-cell therapy and cord blood

BharOS overview

Doxxing definition

Hermit spyware

Prasanth Joseph • Here are a couple of examples of things that are not currently possible, or highly improbable, with gene editing: • Directly Editing Memories: While gene editing can influence brain function to some extent, it cannot directly target and modify specific memories stored in complex neural networks. Our understanding of memory formation and storage is still evolving, and directly editing memories would likely be incredibly difficult, if not impossible, with current technology. • Introducing Entirely New Traits: Gene editing primarily focuses on modifying existing genes or correcting mutations. Adding entirely new complex traits, like granting humans the ability to breathe underwater or fly, would likely require significant modifications across multiple genes and involve a deep understanding of how these genes interact to produce such traits. This is currently beyond the capabilities of gene editing technology. • Bio-Grid • This Bio-Grid will be a National Repository for biological knowledge, information and data. • It is going to be responsible for enabling its exchange, developing measures for safety, • standards and quality for datasets and establishing detailed modalities for accessing data. • ZyCoV-D is a unique vaccine using DNA plasmid technology. It doesn't contain the live virus but instead injects a circular piece of DNA containing the genetic instructions for a specific protein from the SARS-CoV-2 virus. • Covaxin (India): Inactivated Viral VaccineCovaxin is an inactivated viral vaccine. This means it uses a whole SARSCoV-2 virus that has been chemically inactivated (killed) so it can no longer cause illness. The inactivated virus still retains its structure and can be recognized by the immune system, prompting it to develop antibodies to fight the actual virus if encountered later. • Covishield (India): Viral Vector VaccineCovishield is a viral vector vaccine developed by Oxford University/AstraZeneca and manufactured by the Serum Institute of India. It uses a modified version of a chimpanzee adenovirus (a common cold virus) as a carrier. This carrier virus has been engineered to carry the gene encoding the spike protein of the SARS-CoV-2 virus. • Moderna (USA): mRNA VaccineModerna is an mRNA vaccine, a relatively new type of technology. It uses a strand of messenger RNA (mRNA) that carries the genetic instructions for building the specific spike protein found on the surface of the SARS-CoV-2 virus. When injected, the mRNA enters human cells and instructs them to produce the spike protein. • CAR T-cell therapy is indeed a form of gene therapy where T cells are genetically engineered to produce special structures called chimeric antigen receptors (CARs) on their surface. When these CAR T cells are reinfused into the patient’s body, they can bind to antigens on the cancer cells and destroy them. While it has shown promise in treating certain blood cancers, its use in solid tumors is still under research and not the primary application as of the latest updates. The therapy does involve the use of engineered viruses to introduce the CAR genes into T cells. • Cord blood is the blood that remains in the umbilical cord and placenta after a baby is born. It's a rich source of stem cells, which have the potential to develop into many different types of cells found in the body, such as red blood cells, white blood cells, and platelets.Cord blood is indeed rich in hematopoietic stem cells, which have the potential to treat a variety of diseases. private cord blood banks store cord blood for exclusive use by the donor or the donor’s family, not for public use. ICMR does not recommend private cord blood banking for future self-use unless there is an existing child with a condition treatable with these cells, and the mother is expecting another baby. The ICMR has expressed concerns about the lack of scientific basis for the practice of commercial cord blood banking for future self-use. Bh

FAQs

Why is directly editing specific memories not currently possible with gene editing?

Gene editing affects brain function to some extent but cannot precisely target and modify particular memories within complex neural networks. Memory formation and storage mechanisms are still evolving, making direct memory editing highly difficult with current technology.

What is the main idea behind the Bio-Grid repository?

The Bio-Grid is intended as a national repository for biological knowledge, information, and data. It aims to support data exchange, safety measures, standards for datasets, and detailed modalities for accessing data.

What does doxxing mean and what consequences are described?

Doxxing is revealing someone’s intimate information with harassment as the intent. The text notes that private details like addresses and phone numbers can be used to escalate harm, including contacting SWAT teams or armed police.

Sep 20, 2026

Upload by Eden